Download David M. Jablons, MD

各位醫學界先進平安：
惡性腫瘤多年來一直位居國人十大死因之首，為此國家投入大量的資源於癌症
醫學的發展，並訂出｢2011-2020 年，10 年降低癌症死亡率 20%｣的政策目標。有鑑於
此，馬偕紀念醫院謹訂於 104.04.25(星期六)舉辦｢2015 International Symposium on
Cancer Research｣，會中將邀請多位國內外學者進行演講，分享他們於研究和醫療的
最新進展。敬邀各位先進蒞臨指導，共襄盛舉!
時間：2015 年 4 月 25 日(星期六) 09:00-16:10
地點：馬偕紀念醫院台北總院(台北市中山北路二段 92 號)
內外科場次 福音樓 9 樓第一講堂
婦癌科場次 平安樓 15 樓階梯講堂。
活動網址：http://www.mmh.org.tw/research/news_02.htm。
報名網址：https://trns.mmh.org.tw/seminar/SemiLink.asp。
積分：
中華民國癌症醫學會
台灣內科醫學會
台灣外科醫學會
台灣婦產科醫學會
台灣消化系醫學會
申請中
申請中
申請中
申請中
申請中
Keynote Speakers
Professor William C. Dooley, USA
Professor David M. Jablons, USA
Dr. Shinpei Sato, Japan
Dr. Judy Wai-Chu Ho, Hong Kong
Professor Chien-Fu Hung, USA
Professor Michael J. Birrer, USA
2015 International Symposium on Cancer Research
Date: April 25, 2015(Saturday)
Venue: MacKay Memorial Hospital, Taipei, Taiwan
(一) Lecture Hall 1 (Gospel Building, 9th F)
Time
Topic
Speaker
8:30 - 9:00
Reception
9:00 - 9:15
Opening - Professor Yuh-Cheng Yang
Superintendent, MacKay Memorial Hospital
Breast Cancer
Moderator：Dr. Chien-Liang Liu
9:15 - 9:35
Effect of anesthetic technique on breast
cancer surgery
Dr. Yuan-Ching Chang
Department of General Surgery,
MacKay Memorial Hospital, Taipei,
Taiwan
9:35 - 10:35
Using Molecular Sub-type to Direct
Breast Cancer Treatment and
Prevention
William C. Dooley, M.D.
Professor, Department of Surgery, OU
Medicine, USA
10:35 - 10:55
Coffee Break
Lung Cancer
Moderator：Dr. Rong-Luh Lin & Dr. Wen-Chieh Huang
EGFR TKIs for the front-line treatment
of advanced mutated lung
adenocarcinoma
Dr. Pei-Jan Chen
Department of Chest Medicine,
MacKay Memorial Hospital, Taipei,
Taiwan
11:35 - 12:15
Lung Cancer - from bench to bed side:
what a surgeon should know
David M. Jablons, MD
Professor, Department of Surgery,
University of California, San Francisco
USA
12:15 - 13:30
Lunch
10:55 - 11:35
Liver Cancer
Moderator：Dr. Shou-Chuan Shih or Dr. Cheng-Hsin Chu
13:30 - 13:50
Percutaneous Ablation for
Hepatocellular Carcinoma at MacKay
Memorial Hospital: Experiences from
Tokyo to Taipei
Dr. Ching-Wei Chang
Department of Gastroenterology,
MacKay Memorial Hospital, Taipei,
Taiwan
13:50 - 14:10
Percutaneous Ablation for
Hepatocellular Carcinoma at MacKay
Memorial Hospital: Studies from
bedside to bench
Dr. Chia-Yuan Liu
Department of Gastroenterology,
MacKay Memorial Hospital, Taipei,
Taiwan
2
14:10 - 14:50
Expanding the indications for
radiofrequency ablation of
Hepatocellular carcinoma (HCC) or
metastatic tumor
14:50 - 15:10
Coffee Break
Dr. Shinpei Sato
Division of Gastroenterology and
Hepatology, Kyoundo Hospital, Tokyo,
Japan
Cancer Nutrition
15:10 - 15:40
Nutritional support in patients with
colorectal cancer
Dr. Tzu-Chi Hsu
Department of Colon & Rectal Surgery,
MacKay Memorial Hospital, Taipei,
Taiwan
15:40 - 16:10
Nutritional support in the surgical
oncology patients
Dr. Judy Wai-Chu Ho
Department of Surgery, Queen Mary
Hospital, Pokfulam, Hong Kong
16:10 -
Closing
(二) Lecture Hall (Peace Building, 15th F)
Time
Topic
Speaker
9:30 - 10:00
Reception
10:00 - 10:10
Opening - Professor Yuh-Cheng Yang
Superintendent, MacKay Memorial Hospital
Gynecologic Cancers
Moderator：Dr. Kung-Liahng Wang
10:10 - 10:40
Mesothelin as a potential target for the
immunotherapy of ovarian cancer
10:40 - 11:00
Coffee Break
11:00 - 11:40
Mark ovarian cancer cells for cytotoxic
T cells attack through coating with viral
antigenic peptides
11:40 - 12:10
Ovarian cancer vaccine- what did we
learn?
12:10 - 13:00
Lunch
Dr. Wen-Fang Cheng
Department of Obstetrics and
Gynecology, National Taiwan
University Hospital, Taiwan
Dr. Chien-Fu Hung
Department of Pathology, Johns
Hopkins University, Baltimore, MD,
USA
Dr. Chih-Long Chang
Department of Obstetrics and
Gynecology, MacKay Memorial
Hospital, Taipei, Taiwan
Moderator：Dr. Ming-Shyen Yen
13:00 - 13:30
Molecular mechanisms of synergistic
effect of proteasome inhibitors and
platinum-based therapy in solid tumors
3
Dr. Tzu-Hao Wang
Department of Obstetrics and
Gynecology, Linkou Chang-Gung
Memorial Hopstial, Taoyuan, Taiwan
13:30 - 13:50
Coffee Break
13:50 - 14:20
COL11A1 as a determinant of tumor
progression and chemosensitivity in
epithelial ovarian cancer
Dr. Cheng-Yang Chou
Department of Obstetrics and
Gynecology, National Cheng Kung
University Hospital, Tainan, Taiwan
14:20 - 15:00
The genomics of epithelial ovarian
cancer: its impact on the management
of the disease
Professor Michael J. Birrer
Department of Medicine, Harvard
Medical School. Director, Gillette
Center for Gynecologic Oncology,
Medicine, Massachusetts General
Hospital, Boston, MA, USA
15:10 -
Closing
4